| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,014 |
26,665 |
$1.29M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,170 |
6,500 |
$301K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,365 |
9,146 |
$254K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,945 |
2,940 |
$245K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,650 |
2,645 |
$233K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,599 |
2,585 |
$204K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13,423 |
6,251 |
$181K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,982 |
8,202 |
$166K |
| S8301 |
Infection control supplies, not otherwise specified |
5,440 |
4,656 |
$157K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,934 |
1,849 |
$147K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,738 |
10,095 |
$146K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,010 |
7,042 |
$51K |
| 87428 |
|
588 |
558 |
$42K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,346 |
3,537 |
$34K |
| 87807 |
|
2,864 |
2,561 |
$31K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,516 |
1,439 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
878 |
750 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
106 |
105 |
$9K |
| 0071A |
|
185 |
185 |
$7K |
| 0072A |
|
174 |
174 |
$7K |
| 90461 |
|
1,246 |
1,015 |
$6K |
| 81002 |
|
1,506 |
1,430 |
$4K |
| 96160 |
|
896 |
893 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
744 |
624 |
$1K |
| 0081A |
|
34 |
34 |
$1K |
| 97169 |
|
26 |
25 |
$970.40 |
| 99050 |
|
101 |
101 |
$806.76 |
| 0082A |
|
18 |
18 |
$720.00 |
| 99051 |
|
38 |
37 |
$552.78 |
| 85027 |
|
51 |
47 |
$266.07 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
12 |
$214.65 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
43 |
43 |
$173.16 |
| 80061 |
Lipid panel |
13 |
13 |
$146.25 |
| 90686 |
|
2,807 |
2,802 |
$43.37 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
5,244 |
5,233 |
$40.32 |
| 90677 |
|
357 |
356 |
$0.14 |
| 90621 |
|
507 |
505 |
$0.02 |
| 3725F |
|
3,018 |
3,011 |
$0.00 |
| 90670 |
|
1,161 |
1,157 |
$0.00 |
| 90710 |
|
541 |
539 |
$0.00 |
| 90633 |
|
590 |
587 |
$0.00 |
| 90734 |
|
620 |
618 |
$0.00 |
| 90655 |
|
177 |
177 |
$0.00 |
| 91308 |
|
88 |
80 |
$0.00 |
| 90685 |
|
117 |
116 |
$0.00 |
| 99173 |
|
13 |
13 |
$0.00 |
| 90672 |
|
55 |
54 |
$0.00 |
| 90700 |
|
37 |
37 |
$0.00 |
| 90715 |
|
92 |
92 |
$0.00 |
| 90658 |
|
25 |
25 |
$0.00 |
| 90647 |
|
572 |
570 |
$0.00 |
| 91307 |
|
443 |
393 |
$0.00 |
| 90696 |
|
63 |
63 |
$0.00 |
| 3008F |
|
7,193 |
7,173 |
$0.00 |
| 2001F |
|
7,190 |
7,170 |
$0.00 |
| 90651 |
|
810 |
806 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
688 |
580 |
$0.00 |
| 90698 |
|
459 |
458 |
$0.00 |
| 90680 |
|
943 |
940 |
$0.00 |
| 97802 |
|
577 |
573 |
$0.00 |
| 90723 |
|
65 |
65 |
$0.00 |
| 90660 |
|
44 |
44 |
$0.00 |
| 90744 |
|
26 |
26 |
$0.00 |